Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: absent (23), missing (300), gone (960)

Southampton experts develop computer model of hand to improve finger joint surgery

Description: Southampton experts develop computer model of hand to improve finger joint surgery
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/May-2017/Southampton-experts-develop-computer-model-of-hand-to-improve-finger-joint-surgery.aspx

CHINA Protocol v2 4.1.11

Description: REC reference 10/H0501/67 1 The CHildren's INterval Appendicectomy (CHINA) Study A Prospective Randomis
Url: /Media/Southampton-Clinical-Research/Research-protocol/CHINA-Protocol-v2-4.1.11.pdf

Procedure for MIE pinch-grip analyser

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC)
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-MIE-pinch-grip-analyser.pdf

Audit and Risk Committee ToR March 2026

Description: Audit and Risk Committee Terms of Reference Version: 8 Date Issued: Review Date: Document Type: 10 March 2026 January 2027 Committ
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Audit-and-Risk-Committee-ToR-March-2026.pdf

Audit and Risk Committee ToR March 2025

Description: Audit and Risk Committee Terms of Reference Version: 7 Date Issued: Review Date: Document Type: 11 March 2025 January 2026 Committ
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Audit-and-Risk-Committee-ToR-March-2025.pdf

Carboplatin Paclitaxel EC Pembrolizumab Neoadjuvant Ver1.0

Description: Chemotherapy Protocol BREAST CANCER PEMBROLIZUMAB WITH CARBOPLATIN/PACLITAXEL AND EC NEOADJUVANT BREAST CANCER FOLLOWED BY ADJUVANT PEMBROLIZUMAB Regimen • Breast-Pembrolizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Paclitaxel-EC-Pembrolizumab-Neoadjuvant.pdf

Finance and Performance Reports 2024-25 Month 5 August 2024

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose: Finance Report 2024-25 Month 5 N/A – No meeting Ian Howard
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Finance-and-Performance-Reports-2024-25-Month-5-August-2024.pdf

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description: Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pe
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

Carboplatin-Pembrolizumab-Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC 5)-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Carboplatin (AUC5)-Pembrolizumab-Peme
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pembrolizumab-Pemetrexed.pdf

Audit and Risk Committee ToR Jan 2023

Description: Audit and Risk Committee Terms of Reference Version: 5 Date Issued: Review Date: Document Type: 31 January 2023 January 2024 Commi
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2023.pdf

151 to 160 of 413

Previous … 14 15 16 17 18 … Next